Androgen deprivation therapy (ADT) is a staple of treatment for prostate cancer, but a recent study adds to a growing body of evidence that it places men at higher risk of cognitive decline.
Recent research finds that regardless of the drug selected, physicians should exercise caution when prescribing antipsychotics to Alzheimer’s patients.
With research yielding sometimes discordant findings regarding long-term medical risks of football, physicians are looking for answers for parents concerned about youth participation.
Circadian rhythm disorders, such as irregular sleep-wake rhythms, are hallmarks of Parkinson’s disease. The medical community has traditionally believed the disorders are a side effect of Parkinson’s, but a recently published study is challenging that view.
Arterial stiffness in people as young as their 40s can contribute to Alzheimer’s risk, data from the Framingham Heart Study show.
Researchers are developing a means to quickly dissolve blood clots using a drug-and-device combination that also reduces vascular injury.
The lack of a medication to treat primary-progressive multiple sclerosis (PPMS) is a source of frustration for clinicians and patients. The results of a recent phase 3 study of the drug ocrelizumab may be cause for hope.
A virtual reality game-based application is a useful tool for diagnosing mild cognitive impairment (MCI) — a condition that frequently precedes Alzheimer’s — suggests a recent study in the Journal of Alzheimer’s Disease.
A study by the National Institute of Allergy and Infectious Diseases (NIAID) yielded extended remissions for patients coping with relapsing-remitting multiple sclerosis (RRMS).
Looking for reading material for patients curious about undergoing transcranial electrical brain stimulation to improve their mood or memory? A meta-analysis by Australian researchers may be a good place to start, at least when it comes to answering questions from patients eager to improve cognition.
- 1 of 4
- next ›